Features of the Dopaminergic Neurotoxin MPTP
- 1 May 1992
- journal article
- review article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 648 (1) , 96-104
- https://doi.org/10.1111/j.1749-6632.1992.tb24527.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridinePublished by Elsevier ,2002
- 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particlesBiochemical and Biophysical Research Communications, 1990
- Carrier-independent entry of 1-methyl-4-phenylpyridinium (MPP+) into adrenal chromaffin cells as a consequence of charge delocalizationBiochemical and Biophysical Research Communications, 1990
- A sheep model for MPTP induced parkinson-like symptomsLife Sciences, 1989
- Monoamine oxidase activity and distribution in marmoset brain: implications for MPTP toxicityNeuroscience Letters, 1988
- Mechanism of oxidation of 1-methyl-4-phenyl-2,3-dihydropyridinium (MPDP+)Biochemical and Biophysical Research Communications, 1987
- Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytesChemico-Biological Interactions, 1987
- Hemiparkinsonism in monkeys after unilateral internal carotid artery artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1986
- IV. Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effectsLife Sciences, 1985
- V. Potential bioactivation pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Life Sciences, 1985